AgomAb Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AGMB and other ETFs, options, and stocks.About AGMB
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives.
CEOTim Knotnerus
CEOTim Knotnerus
Employees—
Employees—
HeadquartersAntwerp, Flemish Region
HeadquartersAntwerp, Flemish Region
Founded2017
Founded2017
Employees—
Employees—
AGMB Key Statistics
Market cap788.80M
Market cap788.80M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume148.16K
Average volume148.16K
High today$16.34
High today$16.34
Low today$15.59
Low today$15.59
Open price$15.92
Open price$15.92
Volume89.72K
Volume89.72K
52 Week high$16.65
52 Week high$16.65
52 Week low$12.66
52 Week low$12.66
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.